This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
ABSTRACT
Investigators from multiple institutions in France conducted a randomized controlled trial to determine if high-flow nasal cannula (HFNC) is a noninferior treatment compared to nasal continuous positive airway pressure (nCPAP) in treating infants with acute viral bronchiolitis (AVB). Infants 1–6 months old with AVB who were admitted to 1 of 5 pediatric intensive care units in France were eligible for the study if they had a modified Wood clinical asthma score (mWCAS) of >3, indicative of moderate …
Individual Login
Institutional Login
You may be able to gain access using your login credentials for your institution. Contact your librarian or administrator if you do not have a username and password.
Log in through your institution
Purchase access
In this issue
Jump to section
Related Articles
Cited By...
- No citing articles found.